Summary
This prediction ended on 26.01.17 with a price of €107.10. With a performance of 5.67%, the BUY prediction by papaver for Bayer AG closed with a slight gain. papaver has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Bayer AG | -6.490% | -6.490% | -44.241% | -41.437% |
iShares Core DAX® | 2.275% | 4.627% | 18.839% | 16.367% |
iShares Nasdaq 100 | 6.015% | 2.007% | 23.636% | 35.232% |
iShares Nikkei 225® | 4.456% | 3.598% | 12.437% | -0.660% |
iShares S&P 500 | 4.061% | 2.876% | 23.447% | 38.511% |
Comments by papaver for this prediction
In the thread Bayer AG diskutieren
Bayer auf der Gewinnspur
Bayer wird Monsato übernehmen.
Dividende von 3% winkt.